Flen Health
Live the Life you love!

Flen Health believes biotech innovations can help to build a securer life for you and for every human being. Flen Health wants to improve the quality of life of people suffering from skin disorders in a responsible way, by providing added value for patients, healthcare professionals, health authorities and the environment. 

Flen Health was established in 2000, building on the results of wound-treatment research performed by its managing director, Philippe Sollie, a pharmacist. Based on patented technologies, Flen Health developed and commercializes a number of innovative wound and skin healing solutions. Flen Health holds an ISO 13485 certificate that covers all its operations.

Thanks to the success on the Belgian market, Flen Health initiated its international expansion. This resulted in the establishment of further affiliates across Europe (in The Netherlands, Luxembourg, UK & Germany), managed by over 100 motivated employees. Flen Health products are distributed in 25 countries all over the world.
 
Current product portfolio: Flaminal® Hydro, Flaminal® Forte, Flamigel®, Flamigel®RT, Flamirins® and extracalm®.

Direct customers are mainly healthcare professionals: Flaminal® Hydro/Forte indicated for all kind of wound treatments and Flamigel® RT for skin damage caused by radiotherapy. 
 
Flen Health continues to expand its activities and invites motivated and dynamic people to join. Feel welcome to visit our website for more information:

Biotechnology

Health Care

Medical Devices

Flen Health

Flen Health's headquarters in Esch sur Alzette, Luxembourg

Philippe Sollie

Marie van der Gucht

Julie Kerckhof

Andy Wilding

Nicolas Deleye

Frédérique Sine

Kim vander Haegen

Melanie S.

Robin Nicholson

Flen Health

Org chart

Teams

Offices

Similar companies